Baylor Genetics to Provide PGx, Germline Genetic Testing to Veterans Affairs Department
Baylor Genetics’ multiyear national contract with the U.S. Department of Veterans Affairs will greatly expand veterans’ access to precision diagnostics—helping VA providers tailor medications, reduce adverse drug reactions, identify hereditary cancer risk, and ultimately support more timely, personalized care.
“Baylor Genetics is deeply honored to support the VA in expanding nationwide access to advanced precision diagnostics for veterans,” Kengo Takishima, Chairman and CEO of Baylor Genetics, said in a statement. “By providing high-quality genetic insights, we aim to empower VA providers with the tools they need to improve treatment outcomes and ensure that those who have served our country receive the best possible care.”
Read the full article on the GenomeWeb website.
About Baylor Genetics
Baylor Genetics is a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, from clinical-grade genomic sequencing to expert interpretation, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels. Baylor Genetics combines rapid and comprehensive precision diagnostics options with the support of genetic counselors to help clinicians avoid a lengthy diagnostic odyssey for their patients, guide medical management, and ensure no patient with a genetic disorder gets left behind. Baylor Genetics’ testing menu covers family planning, pregnancy, neonatal and pediatric testing, oncology, pharmacogenomics and many other specialized testing options. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states.
